Roche’s antibody cocktail for COVID-19 may face affordability issues in India: GlobalData
Considering that it is a combination of two recombinant human immunoglobulin G-1 (IgG1) monoclonal antibodies, it is expected to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Pharma firms not providing mandated quantity of Remdesivir to Maharashtra: Rajesh Tope
Tope had earlier claimed that DoP was slow in granting clearance to essential medical items imported by the state government
Russia authorises single-dose Sputnik Light COVID vaccine for use
One of its main potential uses is as a vaccine that can be shipped to a country in the grip of an acute outbreak that needs to be…
US backs proposal to waive patents for COVID-19 vaccines
The Biden administration has backed this initiative by India and South Africa at the WTO despite stiff opposition from major…
Roche gets EUA in India for antibody cocktail (Casirivimab and Imdevimab) to treat COVID-19
Partners with Cipla for pan-India distribution
16.5 lakh vials of remdesivir to be allocated between 3rd and 9th May: Gowda
Union Minister Gowda also stressed on the need to continuously monitor availability of other essential medicines and to check…
Eli Lilly accelerates baricitinib’s availability in India
Lilly is working with the Indian government to provide baricitinib donations in conjunction with the permission
RBI announces on-tap liquidity window of Rs 50,000 cr for healthcare infra, services firms
The facility of on-tap liquidity with a tenure of up to three years at the repo rate will remain open till 31st March, 2022
Three-fold increase in remdesivir production in India: Mansukh Mandaviya
Production has gone up from 37 lakh on 12th April, 2021 to 1.05 crore on 4th May, 2021
Oxygen crisis and the law: Life bottled in a cylinder?
Praveen Raju, Founding Partner; Renuka Abraham, Senior Associate and Riddhi Joshi, Associate at Spice Route Legal elaborate on…
MoHF&W issues guidelines for COVID-19 vaccine import by private sector
MoHF&W has said that the ready-to-use imported COVID vaccine would be allowed to be utilised entirely in the…
Serum Institute of India to make £240 mn investments in UK
Serum’s investment will support clinical trials, research and development and possibly manufacturing of vaccines
PIL in HC seeks all remdesivir makers be allowed to sell it in domestic market
A bench issued notice to the health ministry, CDSCO, DGFT and various pharma companies, seeking their stand on the plea that…
SII endorses receiving Rs 1,732 crore for 11 crore doses of Covishield vaccine
The company's response came after the Health Ministry in a statement refuted the allegations that it has not placed any fresh…
Centre has so far provided over 16.54 crore vaccine doses to states/UTs for free
59,70,670 vaccine doses will be received in addition by the states/UTs within the next three days
NATCO receives emergency-use approval for Baricitinib tablets for COVID-19 treatment
Baricitinib, in combination with Remdesivir, is used for treatment of COVID-19-positive patients
Pfizer in talks with India over expedited approval for COVID-19 vaccine
Albert Bourla, CEO, Pfizer also announced a donation of medicines worth more than $70 million
More than 78 lakh COVID vaccine doses still available with states and UTs: Centre
Implementation of the Liberalised and Accelerated Phase 3 Strategy of COVID-19 vaccination started on Saturday, it informed
Dr Reddy’s announces arrival of first consignment of Sputnik V vaccine in India
The rollout of the consignment will be subject to the necessary clearances, which will be processed over the next few days
WHO issues Emergency Use Listing for Moderna’s COVID-19 vaccine
The EUL pathway involves an assessment of late-stage clinical trial data as well as data on safety, efficacy and quality by…